Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftin 1% Cream in Adolescent Tinea Cruris
NCT01885156Phase 3Completed
- Sponsor
- Merz
- Start
- Aug 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of naftifine organogel (MediQuest Therapeutics) in Tinea cruris (TC), sponsored by Merz. Started Aug 2013; status: completed.
02
Drugs
naftifine organogel (MediQuest Therapeutics)
03
Conditions
Tinea cruris (TC)
Beyond the preview
Go deeper on NCT01885156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885156.